Radiation Flashcards

1
Q

What is control rate for 50Gy on LN > and < 10mm

A

Wakatsuki et al have described a
- 97% control rate with 50 Gy radiotherapy for lymph nodes <10 mm in patients with cervical cancer i
- 76% for nodes >10 mm.
Similar results were found by Oh et al in 310 patients with locally advanced cervical cancer with a follow-up of 83 months. In-field failure rates for pelvic, as well as para-aortic lymph nodes >10 mm, were significantly higher than for smaller lymph nodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many Gy to the Ovaries are required to ablate the oocytes

A

POI occurs with a dose of 20Gy in women under 40. Less for women over 40
The mean lethal dose for human oocytes is estimated to be 2Gy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 main volumes in RT planning

A

The known actual tumour is the Gross tumour volume (GTV)
TO ensure that disease outside of the GTV is treated a clinical tumour volume (CTV) is created to cover sublinical spread.
The CTV is placed in a planning target volume (PTV) - this is the area that received the treatment dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are organs at risk and how are they incorporated into RT planning

A

The OR have a planning volume placed around them to reduce toxicity. This is planning Organ at RIsk (PRV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does oxygen effect the effectiveness of RT

A

Oxygen is required to make DNA damage permanent. Hydroxy free radicals react with and damage DNA. In an anoxic environment the DNA is able to be repaired. In an oxic enviornment the damage is made permanent. the Oxygen Enhancement Ratio can be up to 3. meaning 3x dose required in hypoxic environment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does RT work?

A

Directly by damaging DNA and indirectly by creating OH free radicals that interact with and damage DNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is image guided adaptive Brachytherapy

A

IGABT 3D technique uses CT or MRI based planning to escalate the dose to target and reduce dose to adjacent tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is tumour related Leukocytosis

A

Investigated as a marker of radiation sensitivity. Identified that the level of serum leukocytes correlated with response to radiotherapy.
2 levels > 9 in the absence of infection have a lower radiotherapy response rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 6 mechanisms for late RT toxicity?

A

AV FISH
A - Atrophy - loss of fibrocytes and collagen reabsorption
V - Vascular damage - either small vessel dilation or cons- Proliferation of surviving fibrocytes owing to growth factors released as a result of injury

F - Fibrosis
I- Infertility
S - Second Malignancies
H- Hormone deficiences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

In the EMBRACE Trial what was the 5yr overall incidence of Gr 3 AE after radical treatment for cervix cancer?

A
Genitourinary: 4.7%
Gastrointestingal: 4.3%
Vaginal 4.0%
Fistula 1.0%
Overall 10.2%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

From PORTEC 3

What was the rate of late GI toxicity in both RT and CCRT groups

A

Grade 2 - 12 months 7-8%, 60 months 5 - 8%

Grade 3/4 - 12 months 1-2% 60 months 1%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

From PORTEC 3

What was the rate of late genitourinary toxicity in both RT and CCRT groups

A

Grade 2 - 12 months 4-6%, 60 months 6 - 8%

Grade 3/4 - 12 months 0% 60 months 0%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is rate of acute and late toxicity for vulva radiotherapy in a cohort of 39 women with primary and adjuvant IMRT

A
Skin;  Gr 1 - 23 % Gr 3 69%
GI - Gr 1 5%, Gr 2 33%
Acute GU Gr 1 - 5%, Gr 2 10%
Late GI - Gr 1 5%, Nil Gr 2 or above
Late GU Gr 1 5%, Nil Gr 2 or above.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a cell cycle survivial curve?

A

Cell survival curve describes the relationship between the surviving fraction of cells (i.e. the fraction of irradiated cells that maintain their reproductive integrity (clonogenic cells)) and the absorbed dose.
Cell survival as a function of radiation dose is graphically represented by plotting the surviving fraction on a logarithmic scale on the y axis against the dose on a linear scale on the x-axis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a therapeutic index

A

Plot of the probability of tumor control in Y axis against radiation dose in X axis what we get is the tumor control probability (TCP).
Normal tissue complications similarly plotted we get the normal tissue complication probability (NTCP)
TCP and NTCP curves are sigmoid in shape.
The therapeutic index (TI) defines how the TCP relates to NTCP for different doses of radiation
May be called toxicity or dose reponse curves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WHy does chemo RT work?

A

REACH

Repopulation - inhibits accelerated repopulation of tumour cells that occurs after RT
Enhancement - Direct enhancement of DNA damage by incorporating drugs into DNA
Accumulation - cells in a radiosensitive phase or eliminates radioresistant cells
Cellular - inhibiting cellular repair
Hypoxic - eliminating hypoxic cells.

17
Q

What is the dose rate effect of CT

A

The dose rate effect is the increase in cell survival seen as the rate of dose delivery falls.

18
Q

What are the 4 R’s of RT?

A

Repair - Fractionation allows sublethal damage to be repaired. This means a higher total dose is needed to get the same effect as higher doses in less fractions.

Repopulation - protraction reduces teh effectivenes of radiation by permitting time for repopulation. normal tissues repopulate faster but limit the contraction of a course of fractional radiation. Chemo may trigger an increase in the proliferation of the surviving Ca cells -which may increase the determinal affects of treatment delays

Redistribution - RT most effective in late G2 phase and during mitosis. MOst resistant in the mid to late S and early G1 phase. Fraction of RT tends to synchronis cells by killing off cells in sensitive parts of the cell cycle.

Reoxygenation - Hypoxic cells tend to become better oxygenated during a course of fractioned irradiation - called reoxygenation

19
Q

What are contraindications to radiotherapy?

A

prevoius radiation to the area
Pregnancy
Connective tissue disorders (relative)
Inherited sensitivity syndromes e.g. ataxia telangestasia

20
Q

What does VMAT stand for

A

Volumetric Mediated Arc Therapy

21
Q

What is the standard dosage given to a locally advanced cervical cancer

A

45 Gy to primarily turmou and reuigal lymphadtics
Brachtherapy boost of 30 - 40 Gy with image guidance or to point A for a total point A dose of 80 Gy to small vol or 85 to large vol tumours
Involved nodes may be boosed with additional 10 - 15 Gy of highly conformal and reduced volume EBRT.

22
Q

In vulvar cancer the risk of non SLN involvement increases with the size of the SLN metastases. For an ITC in the SLN what is the risk of a non SLN being involved?

A

4.2% (1 in 25 will have another +ve LN)

23
Q

In vulvar cancer the risk of non SLN involvement increases with the size of the SLN metastases. For metastases <2mm in size what is the risk of a non-SLN being involved?

two of 19 with metastases 2 mm or smaller;
two of 15 with metastases larger than 2 mm to 5 mm; and
ten of 21 with metastases larger than 5 mm. Disease-specific survival for patients with sentinel-node metastases larger than 2 mm was lower than for those with sentinel-node metastases 2 mm or smaller (69·5% vs 94·4%, p=0·001).

A

Two out of 19 women with metastases 2 mm or smaller will have another LN +ve

24
Q

In vulvar cancer the risk of non SLN involvement increases with the size of the SLN metastases. For metastases >2 and = 5mm <2mm in size what is the risk of a non-SLN being involved?

ten of 21 with metastases larger than 5 mm. Disease-specific survival for patients with sentinel-node metastases larger than 2 mm was lower than for those with sentinel-node metastases 2 mm or smaller (69·5% vs 94·4%, p=0·001).

A

2 of 15 women with a +ve SLN >2 and = 5mm in size with have an additional +ve LN.

25
Q

In vulvar cancer, the risk of non-SLN involvement increases with the size of the SLN metastases. For metastases >5mm in size what is the risk of a non-SLN being involved?

A

10 of 21 with a LN met >5mm will have another +ve LN.

26
Q

What is the source used for Brachy at Westmead?

A

Iridium 192 (Ir 192)